← Home
McKesson is flourishing, thanks to the stellar performance of its US pharmaceuticals segment, particularly with rising sales of specialty and branded drugs. The company now anticipates its 2025 profit to land between $32.40 and $33 per share, a notable increase from its earlier projection
Stock Swings
Price Drops
No drop incidentsPrice Hikes
+5.76% closed: 2024-11-15Wait! There's more — sign up for free or log in